Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Febrile Seizure Risk After Vaccination in Children 6 to 23 Months.

Duffy J, Weintraub E, Hambidge SJ, Jackson LA, Kharbanda EO, Klein NP, Lee GM, Marcy SM, Nakasato CC, Naleway A, Omer SB, Vellozzi C, DeStefano F; Vaccine Safety Datalink.

Pediatrics. 2016 Jul;138(1). pii: e20160320. doi: 10.1542/peds.2016-0320. Epub 2016 Jun 6.

2.

Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination.

Cheetham TC, Marcy SM, Tseng HF, Sy LS, Liu IL, Bixler F, Baxter R, Donahue JG, Naleway AL, Jacobsen SJ.

Mayo Clin Proc. 2015 Jul;90(7):865-73. doi: 10.1016/j.mayocp.2015.04.021. Epub 2015 Jun 4.

PMID:
26051268
3.

Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures.

Tartof SY, Tseng HF, Liu IL, Qian L, Sy LS, Hechter RC, Marcy SM, Jacobsen SJ.

Vaccine. 2014 Nov 12;32(48):6408-14. doi: 10.1016/j.vaccine.2014.09.055. Epub 2014 Oct 5.

PMID:
25285882
4.

Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort.

Tartof SY, Tseng HF, Liu AL, Qian L, Sy LS, Hechter RC, Marcy SM, Jacobsen SJ.

Vaccine. 2014 May 7;32(22):2574-81. doi: 10.1016/j.vaccine.2014.03.044. Epub 2014 Mar 25.

PMID:
24674662
5.

Safety of the yellow Fever vaccine: a retrospective study.

Nordin JD, Parker ED, Vazquez-Benitez G, Kharbanda EO, Naleway A, Marcy SM, Molitor B, Kuckler L, Baggs J.

J Travel Med. 2013 Nov-Dec;20(6):368-73. doi: 10.1111/jtm.12070. Epub 2013 Oct 10.

6.

Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.

Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM, Daley MF, Belongia EA, Baxter R, Fireman BH, Jackson ML, Omer SB, Nordin JD, Jin R, Weintraub ES, Vijayadeva V, Lee GM.

PLoS One. 2013 Jun 26;8(6):e67185. doi: 10.1371/journal.pone.0067185. Print 2013.

7.

Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years.

Wald ER, Applegate KE, Bordley C, Darrow DH, Glode MP, Marcy SM, Nelson CE, Rosenfeld RM, Shaikh N, Smith MJ, Williams PV, Weinberg ST; American Academy of Pediatrics.

Pediatrics. 2013 Jul;132(1):e262-80.

PMID:
23796742
8.

Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children.

Tseng HF, Sy LS, Liu IL, Qian L, Marcy SM, Weintraub E, Yih K, Baxter R, Glanz JM, Donahue J, Naleway A, Nordin J, Jacobsen SJ.

Vaccine. 2013 May 24;31(22):2578-83. doi: 10.1016/j.vaccine.2013.03.040. Epub 2013 Apr 8.

PMID:
23579258
9.

Vaccination site and risk of local reactions in children 1 through 6 years of age.

Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, Donahue JG, Hambidge SJ, Balsbaugh C, Baxter R, Marsh T, Madziwa L, Weintraub E.

Pediatrics. 2013 Feb;131(2):283-9. doi: 10.1542/peds.2012-2617. Epub 2013 Jan 14.

PMID:
23319538
10.

Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population.

Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, Jacobsen SJ; Vaccine Safety Datalink (VSD) Team.

Clin Infect Dis. 2013 Feb;56(3):315-21. doi: 10.1093/cid/cis871. Epub 2012 Nov 28.

PMID:
23196953
11.

Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population.

Tseng HF, Chi M, Smith N, Marcy SM, Sy LS, Jacobsen SJ.

J Infect Dis. 2012 Jul 15;206(2):190-6. doi: 10.1093/infdis/jis334. Epub 2012 Jun 4.

PMID:
22669900
12.

Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study.

Tseng HF, Liu A, Sy L, Marcy SM, Fireman B, Weintraub E, Baggs J, Weinmann S, Baxter R, Nordin J, Daley MF, Jackson L, Jacobsen SJ; Vaccine Safety Datalink (VSD) Team.

J Intern Med. 2012 May;271(5):510-20. doi: 10.1111/j.1365-2796.2011.02474.x. Epub 2011 Nov 22.

13.

The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization.

Kohl KS, Bonhoeffer J, Braun MM, Chen RT, Duclos P, Heijbel H, Heininger U, Loupi E, Marcy SM; The Brighton Collaboration.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

14.

Paralytic syndromes in children: epidemiology and relationship to vaccination.

Zangwill KM, Yeh SH, Wong EJ, Marcy SM, Eriksen E, Huff KR, Lee M, Lewis EM, Black SB, Ward JI.

Pediatr Neurol. 2010 Mar;42(3):206-12. doi: 10.1016/j.pediatrneurol.2009.10.012.

PMID:
20159431
15.

Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study.

Tseng HF, Smith N, Marcy SM, Sy LS, Chao CR, Jacobsen SJ.

Pediatr Infect Dis J. 2010 Mar;29(3):205-8. doi: 10.1097/INF.0b013e3181bc379b.

PMID:
19952977
16.

Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008.

Tseng HF, Smith N, Marcy SM, Sy LS, Jacobsen SJ.

Pediatr Infect Dis J. 2009 Dec;28(12):1069-72. doi: 10.1097/INF.0b013e3181acf84f.

PMID:
19773676
17.

Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population.

Batra JS, Eriksen EM, Zangwill KM, Lee M, Marcy SM, Ward JI; Vaccine Safety Datalink.

Pediatrics. 2009 Mar;123(3):951-8. doi: 10.1542/peds.2008-0231.

PMID:
19255025
18.

Varicella vaccination and ischemic stroke in children: is there an association?

Donahue JG, Kieke BA, Yih WK, Berger NR, McCauley JS, Baggs J, Zangwill KM, Baxter R, Eriksen EM, Glanz JM, Hambidge SJ, Klein NP, Lewis EM, Marcy SM, Naleway AL, Nordin JD, Ray P, Belongia EA; Vaccine Safety DataLink Team.

Pediatrics. 2009 Feb;123(2):e228-34. doi: 10.1542/peds.2008-2384.

PMID:
19171574
19.

Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems.

Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl K, Marcy SM, Nalin D, Pless R, Sanabria-Rojas H, Sleeman K, Wise R; Brighton Collaboration Methods Working Group.

Vaccine. 2009 Apr 6;27(16):2289-97. doi: 10.1016/j.vaccine.2008.11.035. Epub 2008 Dec 4. No abstract available.

PMID:
19061929
20.

Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies.

Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl KS, Marcy SM, Nalin D, Pless R, Sanabria-Rojas H, Sleeman K, Wise R; Brighton Collaboration Methods Working Group.

Vaccine. 2009 Apr 6;27(16):2282-8. doi: 10.1016/j.vaccine.2008.11.036. Epub 2008 Dec 3. No abstract available.

PMID:
19056451
21.

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.

Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.

PMID:
19047220
22.

This issue: infectious disease emergencies.

Marcy SM.

Pediatr Ann. 2008 Oct;37(10):656-7. No abstract available.

PMID:
18972846
23.

Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.

Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F; Vaccine Safety Datalink Team.

N Engl J Med. 2007 Sep 27;357(13):1281-92.

24.

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data.

Tapiainen T, Prevots R, Izurieta HS, Abramson J, Bilynsky R, Bonhoeffer J, Bonnet MC, Center K, Galama J, Gillard P, Griot M, Hartmann K, Heininger U, Hudson M, Koller A, Khetsuriani N, Khuri-Bulos N, Marcy SM, Matulionyte R, Schöndorf I, Sejvar J, Steele R; Brighton Collaboration Aseptic Meningitis Working Group.

Vaccine. 2007 Aug 1;25(31):5793-802. Epub 2007 May 8. No abstract available.

PMID:
17574313
25.

Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data.

Nell P, Kohl KS, Graham PL, LaRussa PS, Marcy SM, Fulginiti VA, Martin B, McMahon A, Norton SA, Trolin I; Brighton Collaboration Vaccinia Virus Vaccine Adverse Event Working Group for Progressive Vaccinia.

Vaccine. 2007 Aug 1;25(31):5735-44. Epub 2007 May 4. No abstract available.

PMID:
17540484
26.

Eczema vaccinatum as an adverse event following exposure to vaccinia virus: case definition & guidelines of data collection, analysis, and presentation of immunization safety data.

Nell P, Kohl KS, Graham PL, LaRussa PS, Marcy SM, Fulginiti VA, Martin B, Trolin I, Norton SA, Neff JM; Brighton Collaboration Vaccinia Virus Vaccine Adverse Event Working Group for Eczema Vaccinatum.

Vaccine. 2007 Aug 1;25(31):5725-34. Epub 2007 May 2. No abstract available.

PMID:
17532547
27.

Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Beigel J, Kohl KS, Khuri-Bulos N, Bravo L, Nell P, Marcy SM, Warschaw K, Ong-Lim A, Poerschke G, Weston W, Lindstrom JA, Stoltman G, Maurer T; Brighton Collaboration Rash Working Group.

Vaccine. 2007 Aug 1;25(31):5697-706. Epub 2007 Mar 13. No abstract available.

PMID:
17403561
28.

The development of standardized case definitions and guidelines for adverse events following immunization.

Kohl KS, Gidudu J, Bonhoeffer J, Braun MM, Buettcher M, Chen RT, Drammeh B, Duclos P, Heijbel H, Heininger U, Hummelman E, Jefferson T, Keller-Stanislawski B, Loupi E, Marcy SM.

Vaccine. 2007 Aug 1;25(31):5671-4. Epub 2007 Mar 12. No abstract available.

PMID:
17400339
29.

Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study.

Jackson LA, Neuzil KM, Baggs J, Davis RL, Black S, Yamasaki KM, Belongia E, Zangwill KM, Mullooly J, Nordin J, Marcy SM, DeStefano F.

Pediatrics. 2006 Nov;118(5):2032-7.

PMID:
17079576
30.

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F; Vaccine Safety Datalink Team.

JAMA. 2006 Oct 25;296(16):1990-7.

PMID:
17062862
31.

Clinical practice guideline: acute otitis externa.

Rosenfeld RM, Brown L, Cannon CR, Dolor RJ, Ganiats TG, Hannley M, Kokemueller P, Marcy SM, Roland PS, Shiffman RN, Stinnett SS, Witsell DL; American Academy of Otolaryngology--Head and Neck Surgery Foundation.

Otolaryngol Head Neck Surg. 2006 Apr;134(4 Suppl):S4-23.

PMID:
16638473
32.

Compliance with national immunization guidelines for children younger than 2 years, 1996-1999.

Mell LK, Ogren DS, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT; Centers for Disease Control and Prevention Vaccine Safety Datalink Project.

Pediatrics. 2005 Feb;115(2):461-7.

PMID:
15687456
33.

Safety of the trivalent inactivated influenza vaccine among children: a population-based study.

France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R.

Arch Pediatr Adolesc Med. 2004 Nov;158(11):1031-6.

PMID:
15520339
34.

From principles to practice: case-based applications of the acute otitis media guidelines.

Sabella C, Goldfarb J, Francy S, Long JK, Marcy SM.

Cleve Clin J Med. 2004 Jun;71 Suppl 4:S10-8. Review. No abstract available.

PMID:
15462125
35.

New guidelines on acute otitis media: an overview of their key principles for practice.

Marcy SM.

Cleve Clin J Med. 2004 Jun;71 Suppl 4:S3-9. Review. No abstract available.

PMID:
15462124
36.

Fever after immunization: current concepts and improved future scientific understanding.

Kohl KS, Marcy SM, Blum M, Connell Jones M, Dagan R, Hansen J, Nalin D, Rothstein E; Brighton Collaboration Fever Working Group.

Clin Infect Dis. 2004 Aug 1;39(3):389-94. Epub 2004 Jul 9. Review.

PMID:
15307007
37.

Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project.

Eriksen EM, Perlman JA, Miller A, Marcy SM, Lee H, Vadheim C, Zangwill KM, Chen RT, DeStefano F, Lewis E, Black S, Shinefield H, Ward JI.

Pediatr Infect Dis J. 2004 Jul;23(7):656-62.

PMID:
15247605
38.

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization.

Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS; Vaccine Safety Datalink Team.

J Allergy Clin Immunol. 2004 Mar;113(3):536-42.

PMID:
15007358
39.

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.

Marcy SM, Kohl KS, Dagan R, Nalin D, Blum M, Jones MC, Hansen J, Labadie J, Lee L, Martin BL, O'Brien K, Rothstein E, Vermeer P; Brighton Collaboration Fever Working Group.

Vaccine. 2004 Jan 26;22(5-6):551-6. Review. No abstract available.

PMID:
14741143
40.

Risk of anaphylaxis after vaccination of children and adolescents.

Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB, Mullooly JP, Thompson RS; Vaccine Safety Datalink Team.

Pediatrics. 2003 Oct;112(4):815-20.

PMID:
14523172
41.

Management of acute otitis media.

Marcy SM.

Pediatr Infect Dis J. 2003 Jul;22(7):673-4; author reply 674. No abstract available.

PMID:
12867849
42.

Nipple aspirate fluid cytology in breast carcinoma.

Krishnamurthy S, Sneige N, Thompson PA, Marcy SM, Singletary SE, Cristofanilli M, Hunt KK, Kuerer HM.

Cancer. 2003 Apr 25;99(2):97-104.

44.

High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer.

Kuerer HM, Thompson PA, Krishnamurthy S, Fritsche HA, Marcy SM, Babiera GV, Singletary SE, Cristofanilli M, Sneige N, Hunt KK.

Clin Cancer Res. 2003 Feb;9(2):601-5.

45.

Polio extraimmunization in children younger than 2 years after changes in immunization recommendations.

Mell LK, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT; CDC Vaccine Safety Datalink Project.

Pediatrics. 2003 Feb;111(2):296-301.

PMID:
12563054
46.

Childhood vaccinations and risk of asthma.

DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP, Jackson LA, Davis RL, Black SB, Shinefield HR, Marcy SM, Ward JI, Chen RT; Vaccine Safety Datalink Research Group.

Pediatr Infect Dis J. 2002 Jun;21(6):498-504.

PMID:
12182372
47.

Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children.

Zangwill KM, Droge J, Mendelman P, Marcy SM, Partridge S, Chiu CY, Jing J, Chang SJ, Cho I, Ward JI.

Pediatr Infect Dis J. 2001 Aug;20(8):740-6.

PMID:
11734734
48.

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team.

Pediatrics. 2001 Dec;108(6):E112.

PMID:
11731639
49.

Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants.

Yeh SH, Ward JI, Partridge S, Marcy SM, Lee H, Jing J, Curry ES, Howe BJ.

Pediatr Infect Dis J. 2001 Oct;20(10):973-80.

PMID:
11642632
50.

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group.

N Engl J Med. 2001 Aug 30;345(9):656-61.

Supplemental Content

Loading ...
Support Center